Skip to main content

CCTG Connection



Published:
Category: Group updates
PR.24 Team Odette Cancer Centre at Sunnybrook Health Sciences Centre

Congratulations to the PR.24 trial team from Odette Cancer Centre who were presented the Phase III Program Team Award at the 2025 Spring Meeting for their work and dedication to this CCTG led prostate cancer trial. This recognition is awarded to a non-MD team of clinical research associates, nurses, pharmacists and others who participated in this phase III clinical trial to acknowledge their efforts and dedication to the success of clinical trials.

Read More

Published:
Category: Group updates
Iryna Sokolenko - North York General Hospital

CCTG was pleased to present the Excellence in Clinical Trials Conduct award to Iryna Sokolenko at North York General Hospital for her work to support our trials and contributions to patient-focused research. Iryna is the PCRA for CRC.10 and has been recognized as having exceptional attention to detail who's genuine care made participating in the trial a positive experience for patients. This is presented annually to an individual who exemplifies excellence in clinical trial operations and compliance at their institution.

Read More

Published:
Category: Group updates
Dr. Rebecca Wong Princess Margaret Cancer Centre

We are honoured to announce that the 2025 Joseph Pater Founder’s Award for Excellence in Clinical Trials Research has been presented to Dr. Rebecca Wong Princess Margaret Cancer Centre for her many years of trial and committee leadership with the group.She was Chair of CCTG’s Symptom Control (now Supportive Care) Committee from 2001-2018, and Esophageal disease-oriented group from 2009-2018.  She is currently a member of CCTG’s Clinical Trials Committee.

Read More

Published:
Category: News
CRA Lunch and Learn training program

CCTG will be holding the next CRA Lunch and Learn on Wednesday June 11th, 2025, at 12 pm ET. Session 5 will cover the topic of Understanding the Centre Performance Index (CPI)

 

Read More

Published:
Category: Office of the Director
Spring Meeting 2025: Record-Breaking Attendance and Inspiring Achievements

The 2025 CCTG Spring Meeting of Participants wrapped up with a record 941 members attending. This dynamic gathering helped shape our future research agenda and celebrated many achievements across our network.

Read More



Published:
Category: Publications
Publication: EORTC validation study
A meta-analysis completed by the EORTC using data from the following CCTG trials: BR20, BR21, BR24, BR25, BR26, BR29, CE6, CO17, CO20, C023, IND210, MA21, MA31, MY10, OV16, OV21, PA3, SC19, SC20. Read More

Published:
Category: Publications
Publication: EN7 conference abstract
An EN7 conference abstract presented at the United States and Canadian Academy of Pathology Annual Meeting 22-27 March, 2025 in Boston and subsequently published in Laboratory Investigation. 1006 Identifying H&E-based Immune Patterns in Endometrial Carcinoma and Their Association with Clinicopathologic Variables, Tumor Mutational Landscape, and Survival presented at the United States and Canadian Academy of Pathology Annual Meeting 22-27 March, 2025 in Boston and subsequently published in Laboratory Investigation. Read More

Published:
Category: Publications
ASCO GU poster presentations
Congratulations to the researchers who had poster presentations at the ASCO Genitourinary Cancer Symposium in San Francisco, February 13-15, 2025.
 
PRC4 - Ryan CJ, Kim H, Morris MJ, Alyamani M, Diaz R, Beltran H, Armstrong AJ, Sharifi N, Halabi S. Racial differences in organic anion transport proteins (OATP) and outcome in castration resistant prostate cancer treated with AR pathway inhibitors in Alliance A031201: A phase III trial. ASCO Genitourinary Cancer Symposium.
Read More